Login to Your Account



Roche, PTC Partnership Based On Solid Science, Unmet Need

By Catherine Shaffer
BioWorld Today Contributing Writer

Wednesday, November 30, 2011
Roche AG is pumping up its central nervous system (CNS) pipeline with the acquisition of a rare disease program from PTC Therapeutics Inc., of South Plainsfield, N.J.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription